Irritation and Sensitization Study of d-Amphetamine Transdermal System

NCT04094025 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

229

Enrollment

INDUSTRY

Sponsor class

Conditions

Cumulative Irritation and Sensitization

Interventions

DRUG: dATS

Sponsor

Noven Therapeutics